Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Bortezomib for Prostate Cancer
Recruiting1 awardPhase 2
Salt Lake City, Utah
This trial tests if a drug, bortezomib, can help treat prostate cancer in those with PTEN deletion. Patients receive 8 cycles of injections to see if it helps reduce PSA.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service